Skip to content

Evaluation of Siddha Samadhi Yoga for anxiety and depression symptoms: a preliminary study.

Elisa Harumi Kozasa, Ruth Ferreira Santos, Adriana Dourado Rueda, Ana Amélia Benedito-Silva, Felipe Leite Moraes De Ornellas, José Roberto Leite

Psychological Reports August 1, 2008 DOI: 10.2466/pr0.103.1.271-274 (opens in new tab)

Relevant Not relevant

Study at a glance

AI-extracted from the abstract
Characteristics Controlled trial (non-randomized, waiting-list control) Peer reviewed
Sample size 22
Population Adults with anxiety complaints (mean age 42.8 years, SD 10.3)
Duration 1-month follow-up
Measures State-Trait Anxiety Inventory, Beck Depression Inventory, Tension Feelings Self-evaluation Scales, Well-being Self-evaluation Scales
Topics Anxiety Depression Meditation
Keywords Humans Yoga Psychotherapy Adult Middle aged
Key findings Among 22 adults with anxiety complaints, those attending the Siddha Samadhi Yoga program (meditation plus pranayama) showed significant reductions in anxiety, depression, and tension scores and increased well-being one month later, compared with a waiting-list control group.

Abstract

Siddha Samadhi Yoga is a program in which meditation is associated with pranayama (breathing exercises). 22 volunteers with anxiety complaints (M age = 42.8 yr., SD = 10.3) were assigned to two groups: 14 attended the yoga group, and 8 attended a waiting-list or control group. They were evaluated before the intervention and 1 month after it on the State-Trait Anxiety Inventory, the Beck Depression Inventory, Tension Feelings Self-evaluation Scales, and the Well-being Self-evaluation Scales. A significant reduction in scores on anxiety, depression, and tension was found in yoga group, as well as an increase in well-being in comparison with the control group.

Comparable studies

Other non-randomized and open-label trials on anxiety, most cited first.

Study Year Design Participants
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression Patients with treatment-resistant depression 2018 Clinical trial n = 20
Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder Subjects with obsessive-compulsive disorder (OCD) 2006 Controlled clinical trial
Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder Subjects with DSM-IV-diagnosed treatment-resistant major depressive disorder 2010 Open-label trial n = 33
Emotions and brain function are altered up to one month after a single high dose of psilocybin. Healthy volunteers (7 female, 5 male) 2020 Open-label pilot study n = 12
Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study Older long-term AIDS survivor (OLTAS) self-identified gay men with moderate-to-severe... 2020 Open-label study

Citations in the library

Cited by 9

and 4 more in the library

Cites 6

and 1 more in the library

Related reading

Explore topics

Anxiety Depression Meditation Breathwork